Cargando…

2047. Study of Molecular epidemiology, risk factor analysis and comparison of diagnostic methods for rapid diagnosis of fungal pneumonia in critically ill cirrhotics

BACKGROUND: Liver cirrhosis causes immune dysregulation and increased susceptibility to fungal infections. We studiede risk factors, molecular epidemiology and compared the rapid diagnostic methods and biomarkers for fungal pneumonia in critically ill cirrhotics METHODS: Single-center, prospective c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kale, Pratibha Ramchandra, Khillan, Vikas, Sarin, Shivkumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253131/
http://dx.doi.org/10.1093/ofid/ofy210.1703
_version_ 1783373426554044416
author Kale, Pratibha Ramchandra
Khillan, Vikas
Sarin, Shivkumar
author_facet Kale, Pratibha Ramchandra
Khillan, Vikas
Sarin, Shivkumar
author_sort Kale, Pratibha Ramchandra
collection PubMed
description BACKGROUND: Liver cirrhosis causes immune dysregulation and increased susceptibility to fungal infections. We studiede risk factors, molecular epidemiology and compared the rapid diagnostic methods and biomarkers for fungal pneumonia in critically ill cirrhotics METHODS: Single-center, prospective cohort study of 50 critically ill cirrhotics with fungal pneumonia between January and September 2017. Comparative analysis of culture, real-time PCR and biomarkers; Bronchoalveolar lavage and serum galactomannan, serum procalcitonin were measured by ELISA and chemiluminescence assay on Days 1, 3, 7. Final outcome were mortality within 1 month after diagnosis or discharge. Genotyping of clinical and air sampling Aspergillus isolates was done RESULTS: Aspergillus flavus was most common species (34/50, 68%). Risk factors were, neutropenia (P 0.03), steroids prior to ICU admission (P 0.02), prolonged hospitalizations >21 days (P 0.05). Culture positivity was 80%. Culture was not inferior to real-time PCR for diagnosis of fungal pneumonia. BAL Galactomannan was early prognostic marker with median rise above >1 index value on Day 1. Median PCT level was higher from Day 1 in the fungal pneumonia nonsurvivor group (3.29 vs. 0.8 ng/mL) with higher 30-day mortality (72%). Higher PCT was associated with bacterial co-infection (48%), antibiotic(74%) and antifungal therapy and renal failure and mortality. Cinical isolates from patients matched those recovered from air in two clusters. CONCLUSION: Fungal pneumonia complicates cirrhotics with neutropenia, prolonged hospitalization and steroids as risk factors. Aspergillus species predominate as in Asian epidemiology. Culture methods are reliable and combination of molecular test with BAL galactomannan is useful for rapid diagnosis. SerumPCT is raised in patients with fungal pneumonia and associated with higher mortality. In our study the baseline PCT at admission to ICU was higher in nonsurvivor group, levels on D3 and D7 were persistantly higher. High serum procalcitonin level is an independent prognostic biomarker of mortality risk in fungal pneumonia. Genetic relatedness of clinical and environmental sample necessitates infection control measures to prevent invasive aspergillosis in high-risk patients. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6253131
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62531312018-11-28 2047. Study of Molecular epidemiology, risk factor analysis and comparison of diagnostic methods for rapid diagnosis of fungal pneumonia in critically ill cirrhotics Kale, Pratibha Ramchandra Khillan, Vikas Sarin, Shivkumar Open Forum Infect Dis Abstracts BACKGROUND: Liver cirrhosis causes immune dysregulation and increased susceptibility to fungal infections. We studiede risk factors, molecular epidemiology and compared the rapid diagnostic methods and biomarkers for fungal pneumonia in critically ill cirrhotics METHODS: Single-center, prospective cohort study of 50 critically ill cirrhotics with fungal pneumonia between January and September 2017. Comparative analysis of culture, real-time PCR and biomarkers; Bronchoalveolar lavage and serum galactomannan, serum procalcitonin were measured by ELISA and chemiluminescence assay on Days 1, 3, 7. Final outcome were mortality within 1 month after diagnosis or discharge. Genotyping of clinical and air sampling Aspergillus isolates was done RESULTS: Aspergillus flavus was most common species (34/50, 68%). Risk factors were, neutropenia (P 0.03), steroids prior to ICU admission (P 0.02), prolonged hospitalizations >21 days (P 0.05). Culture positivity was 80%. Culture was not inferior to real-time PCR for diagnosis of fungal pneumonia. BAL Galactomannan was early prognostic marker with median rise above >1 index value on Day 1. Median PCT level was higher from Day 1 in the fungal pneumonia nonsurvivor group (3.29 vs. 0.8 ng/mL) with higher 30-day mortality (72%). Higher PCT was associated with bacterial co-infection (48%), antibiotic(74%) and antifungal therapy and renal failure and mortality. Cinical isolates from patients matched those recovered from air in two clusters. CONCLUSION: Fungal pneumonia complicates cirrhotics with neutropenia, prolonged hospitalization and steroids as risk factors. Aspergillus species predominate as in Asian epidemiology. Culture methods are reliable and combination of molecular test with BAL galactomannan is useful for rapid diagnosis. SerumPCT is raised in patients with fungal pneumonia and associated with higher mortality. In our study the baseline PCT at admission to ICU was higher in nonsurvivor group, levels on D3 and D7 were persistantly higher. High serum procalcitonin level is an independent prognostic biomarker of mortality risk in fungal pneumonia. Genetic relatedness of clinical and environmental sample necessitates infection control measures to prevent invasive aspergillosis in high-risk patients. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253131/ http://dx.doi.org/10.1093/ofid/ofy210.1703 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Kale, Pratibha Ramchandra
Khillan, Vikas
Sarin, Shivkumar
2047. Study of Molecular epidemiology, risk factor analysis and comparison of diagnostic methods for rapid diagnosis of fungal pneumonia in critically ill cirrhotics
title 2047. Study of Molecular epidemiology, risk factor analysis and comparison of diagnostic methods for rapid diagnosis of fungal pneumonia in critically ill cirrhotics
title_full 2047. Study of Molecular epidemiology, risk factor analysis and comparison of diagnostic methods for rapid diagnosis of fungal pneumonia in critically ill cirrhotics
title_fullStr 2047. Study of Molecular epidemiology, risk factor analysis and comparison of diagnostic methods for rapid diagnosis of fungal pneumonia in critically ill cirrhotics
title_full_unstemmed 2047. Study of Molecular epidemiology, risk factor analysis and comparison of diagnostic methods for rapid diagnosis of fungal pneumonia in critically ill cirrhotics
title_short 2047. Study of Molecular epidemiology, risk factor analysis and comparison of diagnostic methods for rapid diagnosis of fungal pneumonia in critically ill cirrhotics
title_sort 2047. study of molecular epidemiology, risk factor analysis and comparison of diagnostic methods for rapid diagnosis of fungal pneumonia in critically ill cirrhotics
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253131/
http://dx.doi.org/10.1093/ofid/ofy210.1703
work_keys_str_mv AT kalepratibharamchandra 2047studyofmolecularepidemiologyriskfactoranalysisandcomparisonofdiagnosticmethodsforrapiddiagnosisoffungalpneumoniaincriticallyillcirrhotics
AT khillanvikas 2047studyofmolecularepidemiologyriskfactoranalysisandcomparisonofdiagnosticmethodsforrapiddiagnosisoffungalpneumoniaincriticallyillcirrhotics
AT sarinshivkumar 2047studyofmolecularepidemiologyriskfactoranalysisandcomparisonofdiagnosticmethodsforrapiddiagnosisoffungalpneumoniaincriticallyillcirrhotics